Radio and PodcastRadio and PodcastLive Radio & Podcasts
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System artwork
Science & Medicine

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System

JALM Talk Podcast by American Association for Clinical Chemistry

Jul 24, 202511:13Science & Medicine

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is an episode from JALM Talk Podcast by American Association for Clinical Chemistry. T...

About This Episode

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is an episode from JALM Talk Podcast by American Association for Clinical Chemistry. This science & medici...

Podcast

This episode belongs to JALM Talk Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 24, 2025, 11:13 long, audio available.